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Tolerance affects the specificity of the antibody response. This can be demonstrated 
by injecting an animal  at birth with a  macromolecule and  thereafter  studying the 
immune response to a  different, but structurally related,  macromolecule (1--8). Such 
treatment gives rise to antibodies, directed mainly against structures on the immuniz- 
ing macromolecule which are not present on the tolerance-inducing substance. How- 
ever, there is also reactivity with the tolerance-inducing macromolecule. This can be 
attributed to antibody molecules which are directed against configurationaUy altered 
protein determinants  and which cross-react with  the  corresponding native  determi- 
nants (8). Thus it appears that the tolerant state can be circumvented by injecting a 
cross-reacting antigen.  On the other hand, the tolerant state might be prolonged by 
some of the determinants of a cross-reacting antigen. It is well known that the period 
of tolerance can be extended by the administration of the tolerance-inducing antigen 
during adult life  (9).  This must imply that tolerance to all or most of the individual 
determinants  is thus prolonged. However, many such determinants  are also present 
on a  cross-reacting antigen  and it would therefore seem reasonable to assume that 
tolerance to these shared determinants must be maintained by the injection of cross- 
reacting antigen. Thus two divergent results may develop from such immunization of 
a  tolerant animal; (a) the formation of antibody which may terminate tolerance, and 
(b) the prolongation of tolerance by determinants which are common to the immuniz- 
ing and  tolerance-inducing  macromolecules.  This  is  not likely  to play any part  in 
natural tolerance, but may affect the results of model experiments, and hence needs to 
be analyzed if results of such experiments  are to be related  to the consequences of 
natural  tolerance.  The  following  experiments  were  designed  to  distinguish  and  if 
possible to disentangle the effect of these opposing tendencies. 
Materials and Methods 
Reagents 
Human Albumin (HA).--Human albumin, Behringwerke "reinst"  (Behringewerke, Mar- 
burg-Lahn, West Germany) was used throughout. 
g-Mcrcaploctha~wl was obtained from Eastman Organic Chemicals, Rochester, N.Y. 
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Sodium  radioiodide HA.lalI,  cysteine-free was obtained from Charles E. Frosst, Montreal, 
Quebec, Canada. 
Tannic acid was obtained from British Drug Houses, Toronto, Canada. 
85S-labeled sulfanilio acid was obtained from  the Radiochemical  Centre,  Amersham, Eng- 
land. 
Oxazolone.--2-phenyl  4-ethoxy methylene oxazolone was prepared by Dr. J. A.  Stock of 
the Chester Beatty Institute, London, with and without 14C label. 
Immunological and Analytical Methods 
Preparation of Modified Proteins, Azo Human Albumin (HA-D), and Oxasolonated Human 
Albumin  [HA  (Ox)].--Diazotized sulfanilic acid  coupled to HA was prepared as  previously 
described (1, 2). Three products were prepared which differed in the degree of coupling: HA- 
Ds, HA-DIe,  and HA-D35  (8). HA covalenfly linked to oxazolone was prepared  (HA(Ox)a, 
HA(Ox)3s)  as described by Yoshimura and Cinader (7). The properties of these compounds 
have been described (7, 8). 
lodinated Human Albumin  (HA .mI).--Iodination was carried out by a modification (1) of 
the method of Berson, Yalow, Schreiber, and Post (10). 
Induction of Tolerance in Newborn Rabbits.--Newbom rabbits were injected intraperitone- 
ally with HA dissolved in 0.15  ~  NaCh the first injection was given within 12 hr of birth. 
A total of 20 mg of HA given in four injections was administered within 84 hr after birth. 
Injection of Adult Rabbits.--Injection  of protein dissolved in 0.15  ~  NaC1 was made into 
the marginal vein of the ear. A course of injections consisted of three injections administered 
at intervals of 48 hr. Courses of injections were carried out during the following periods: 44-48, 
69-73, 94-98,  119-123,  144-148,  169-173,  194--198, 219-223, and 244-248 days after birth. 
Animals were bled 5 and 11 days after the last injection of each course. 
Agglutination.--Antibody  levels were measured  by Boyden's method  (11)  involving the 
agglutination of tanned sensitized sheep erythrocytes as described by St. Rose and Cinader 
(8). 
Examination  of the Specificity of Antibodies by Agglutination-Inhibltion.--Tlfis  method has 
been applied in earlier studies of acquired immunological tolerance (1, 7, 8). 
Determination of the A gglutinating Capacity of A ntisera after Preincubation with 2-M  ercapto- 
ethanoL--The  procedure was based on that adopted by Uhr and Finkelstein (12). Serum was 
diluted 1:10 with 0.15  M NaC1 and incubated in a  final concentration of 0.1 M 2-mercapto- 
ethanol at 37°C for 30 min. The agglutination titer was then determined in the presence of 
mercaptoethanol. As a  control, the titer of untreated sera was measured in the same experi- 
ments. 
Elimination  Tests.--Animals to be injected with HA.~8~I were given KI in their drinking 
water during the week preceding the injection. HAY~I was injected into the marginal vein of 
one ear and blood was taken from the opposite ear at intervals of 24 hr. An equal volume of 
20% trichloroacetic acid was added to the sera and the resulting precipitates were separated 
by centrifugation for 30 rain at 2500 rpm. The radioactivity of the intact sera and of the pre- 
cipitates obtained by  treatment with triehloroacetic acid  was  determined. The  log  radio- 
activity, corrected for the half-life of 13~I, was plotted as a function of time. 
The duration of the tolerant state was defined operationally in terms of the elimination 
test.  Animals which eliminated ttAY~I in two phases were considered tolerant, and animals 
which eliminated the protein in three phases were  considered to be nontolerant. All animals 
received the same relative quantity of HAY~I (5.24 mg protein per kg body weight). From the 
elimination curve of animals which eliminate HAYlI in two phases, we determined m0 the ap- 
parent equilibrium concentration at zero time of antigen in the circulation. The value of m0 
was found by extrapolating the curve of the metabolic phase to  zero time. This was found ]3.  CINADER~  J'.  E.  M.  ST,  ROSE,  AND  M.  YOSHIMURA  1059 
to be fairly constant in different  animals and showed a variation of less than 20°/o. We defined 
t0.1 as the time in hours at which the circulating antigen is 0.1% of the amount of antigen m0. 
The value of t0a depends upon the onset of antibody formation. 
RESULTS 
Effect of Cross-Reacting Antigens on Tolerance Maintenance.--We have previ- 
ously examined the duration of the tolerant state in rabbits injected with 20 mg 
of human albumin (HA) at birth. Maintenance of tolerance was defined by the 
diphasic elimination of iodinated human albumin (HA. lalI). In 94 % of animals 
tolerance was maintained for 84 days, in 51% of animals for 139 days, and by 
the  260th day it was lost in  all  animals  (8).  Immunization with chemically 
modified HA during the first 73 days of life did not cause any change in the 
duration of tolerance as judged by the elimination of HA. z81I, injected on day 
85  (7,  8). In the present study, we have examined the effect of cross-reacting 
antigens on the maintenance of tolerance. HA.~31I was injected into 135-day-old 
animals which received p-azosulfonic acid derivatives of HA(HA-D) between 
the 44th and 123rd day. We found that 95 % (20/21) of the animals were tolerant 
(groups I-a, I-b, and I-c, TableI). Thisproportion  of tolerant animals was greater 
than that found among animals injected at birth with HA but not injected with 
cross-reacting antigen (P <  0.001). This was also the case ff administration of 
cross-reacting antigen was confined to two courses of injections given between 
the 44th and 73rd day (P =  0.003), but was not found when the two courses 
were given between the 94th and 123rd day (P >  0.05). Injections during this 
later period, either with HA or HA-Ds resulted in a lower fraction of tolerant 
individuals than did injections with the same quantity of the same antigens be- 
tween the 44th and 73rd day (P <  0.05; comparison of groups I-d and I-e with 
I-f and I-g of Table I). 
We next examined the maintenance of tolerance in animals injected with HA 
at birth and given chemically modified antigens up to the time when tolerance 
would have been lost in all animals had they not received cross-reacting anti- 
gens. To do this, animals were injected with HA at birth, and between the 44th 
and 248th day were given HA-Ds, HA-D85, HA(Ox)s, or HA(Ox)as. FinaUy, on 
the 260th day they were given HA.18zI. A large proportion (50-100 %) of these 
animals maintained tolerance (comparison with animals which received HA at 
birth but no cross-reacting antigens thereafter: 0.001  <  P  <  0.01). The propor- 
tion of animals which maintained tolerance was similar in the groups treated with 
HA-D and HA(Ox) (Table II); there was no difference at the 5 % level; (0.50  < 
P  <  0.70). Further, HA-Ds and HA-D3~ were equally effective in maintaining 
tolerance (0.10  <  P  <  0.20),  whereas HA(Ox)ss was less  effective than  HA 
(Ox)3 (P =  0.012). 
We therefore conclude that tolerance can be prolonged by injecting a cross- 
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It appears also that different cross-reacting antigens may differ in their capacity 
to prolong tolerance. 
Incidence  and Development  of Antibody  Production in  Tolerant Animals.-- 
Having dealt so far with the effect of cross-reacting antigens on the maintenance 
of tolerance, we shall now turn to the response to HA.131I of those animals in 
which prolongation of tolerance did  not occur.  The  time  at  which  the third 
phase of elimination occurred (t0.i)  was determined in these animals and in a 
control group. Animals in the control group received antigen at birth, no cross- 
TABLE I 
Effect of  Cross-Reacting Antigens on  the Maintenance of  Tolerance 
Animals were injected with 20 mg human albumin  (HA) at birth, and were subsequently 
given two to four courses of injections of HA or of p-azo sulfonic acid  derivatives of HA 
(HA-Ds, HA-DIe, and HA-D~). A course consisted of three injections of 5 mg protein each, 
given at 48-hr intervals. These courses of injections were administered on the following days 
after  birth:  44, 46, 48; 69, 71, 73; 94, 96, 98;  and  119, 121, 123. Lightly  iodinated  HA 
(HA)31I) was injected on day 135. 
Group 
I-a 
I-b 
I-c 
I-d 
I-e 
I-f 
I-g 
Days after birth at whichantigen (HA-Dn*) 
was injected 
44, 46, 48 
HA-D~ 
HA-Dis 
HA-Ds 
HA-Ds 
HA 
Nil 
Nil 
69, 71, 73 
HA-D~ 
HA-D16 
HA-Ds 
HA-Ds 
HA 
Nil 
Nil 
94, 96, 98 
HA-D~ 
HA-Dis 
HA-D8 
Nil 
Nil 
HA-Ds 
HA 
119, 121, 123 
HA-D~ 
HA-D16 
HA-D8 
Nil 
Nil 
Ha-Ds 
HA 
Fraction  of 
animals whlch 
eliminated HA.mI 
diphasically 
6/6 
6/6 
8/9 
12/12 
5/5 
9/12 
8/lO 
to.,~ 
hr 
120 
70,100,310 
80,210 
*n was 0, 8, 16, or 35. 
to.1 is the time in hours at which the circulating antigen is 0.1% of too; m0 is found by 
extrapolating  the metabolic phase to zero time. 
reacting antigen thereafter,  and HAylI  between the 84th and the 295th day of 
life. A proportion of these animals lost tolerance. 
The value for t0.1 was shorter in the animals which had received cross-reacting 
antigen  than  in  the  control  animals  (Fig.  1).  The  rapid  onset  of  immune 
elimination  of HAmI in the former group may be connected with  antibodies 
formed against determinants  of the cross-reacting antigens,  and we shall next 
examine the formation of such antibodies. By agglutination of tanned erythro- 
cytes  coated  with  either  HA  or  cross-reacting  antigen  (HA-D8,  HA-D85, 
HA(Ox)8, HA(Ox)3s), antibody could be detected in 48/103 or 52/103 animals, 
respectively. The incidence of responders was highest among animals immunized 
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no increase  in the incidence of responding  animals between the 4th and 9th 
course of injections (Table III). We followed the serum agglutination titer of all 
animals through nine courses of injections.  Animals which had failed to form 
antibody after two courses of injections  with HA-Ds or HA(Ox)3s remained 
unresponsive  to the seven subsequent courses (Fig.  2). 
During progressive immunization, we observed two types of changes of anti- 
body quantity. The rate  of increase  in reciprocal  titers  of the 27  animals 
responding  to HA(Ox)  and  HA-D was greatest after the initial two to four 
TABLE II 
The Elimination  of Iodinated Human  Albumin  (HA.181I) from the Circulation of Animals 
Injected at Birth with Human Albumin  (HA)  and Subsequenay with Derivatives of HA 
Rabbits were injected with 20 mg HA at birth, and were given nine courses of injections 
of derivatives of HA between day 44 and 248. A course consisted of three injections each of 
5 mg protein given at 48-hr intervals. HA.131I was injected intravenously on day 260. 
Group 
II-a 
II-b 
II-c 
II-d 
II-e 
Hapten 
molecule 
attached 
to HA 
p-azo sulfonic acid 
Oxazolone 
None 
Average nmnber 
of hapten groups 
per molecule of 
HA 
8 
35 
8 
38 
Fraction of animals 
which eliminated 
HA.mI 
diphaslcally 
5/10" 
12/16, 
10/10§ 
6/1211 
5/5¶ 
to.2 
kr 
270, 260,  170, 220,  140 
220, 450,  110, 100 
250, 230, 160 
* and * compared with § and [I 0.50  <  P  <  0.70. 
* compared with, 0.10 <  P  <  0.20. 
§ compared with [I 0.001  <  P  <  0.01. 
¶  compared with*+*+§+[[ 0.10 <  P  <  0.20;with*  P  <  O.05;with,  0.10  <  P  <  0.20; 
with § P  >  0.50; with 11 P  <  0.05. 
courses,  and decreased after subsequent immunization. In 16/27  animals,  the 
quantity of agglutinating antibody reached a peak level and then decreased; in 
6 of these 16 animals this resulted in loss of detectable antibody. In the remain- 
ing 11 responding animals (11/27)  a constant level of circulating  antibody was 
reached and maintained. This constant level was observed in most responders 
to HA-Ds (5/6), and in one-third of responders to HA-D35 (3/10)  and to HA- 
(Ox)~s (3/10),  but not in the one responder to HA (Ox)s. 
Reactivity  and Specificity  of Antibody.--The  antibodies of most responders 
(26/27)  agglutinated tanned  erythrocytes coated with native HA.  This re- 
activity was only found in sera which agglutinated tanned erythrocytes coated 
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than that detected with modified antigen. This difference was small in sera from 
animals injected with HA-D8 (average ratio HA-Ds/HA  =  1.4)  and in sera 
Zrom the one animal which responded to HA(Ox)8 (average ratio HA(Ox)8/HA 
]]-d 
TT-b 
II 
Zl 
II 
II 
II 
II 
II 
II 
II 
IIo{ 
I-f  ~  -~ 
l-g  !  a~ 
l-c{  Ill l  llll  II 
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tO. I  (hr) 
FIG. 1.  Distribution of the periods of time (0.i) required for the disappearance of iodinated 
human albumin (I-IA.18iI)  from the circulation of animals which eliminated HA.mI in a tri- 
phasic manner. Animals were injected at birth with 20 mg HA. All animals were later given 
5.24 mg I-IA.ia~I  per kg of body weight intravenously. Number on left hand side of figure refers 
to the number of the table which also describes these animals. The accompanying letter des- 
ignates the group within the table. Number and letter refer only to the broken lines opposite 
them. The solid lines designate animals injected with HA at birth which received I-IAYlI and 
no other injections in later life. Group II-d rabbits were given nine courses of injections of 
I-IA(Ox)88 between day 44 and 248. Groups II-a and II-b were given nine courses of injections 
of I-IA-Ds  and I-IA-Da6  respectively between day 44 and 248. All ~nlmaJs  of groups II-d, II-b, 
and II-a were injected with I-IA.Z3iI  at age 260 days. Animals of group I-c were given four 
courses of injections of I-IA-D8  between day 44 and 123. ,~nlmals of groups I-f and I-g were 
given two courses of injections of HA-D8 and I-IA respectively between day 94 and 123. All 
animals of groups I-f, I-g, and I-c were injected with I-IA.mI  on day 135. 
=  1.8) ; it was much larger in sera from animals injected with HA-Da6 (average 
ratio HA-D3s/HA =  6.1)  and HA(Ox)a8 average ratio HA(Ox)as/HA =  6.2). 
In 2/16 responders to HA-D and in 6/9 responders to HA(Ox)~ antibodies re- 
active with modified antigen could be detected in sera in which antibodies could 
no longer be detected with native HA. 
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examined by the agglutination-inhibition test, employing tanned erythrocytes 
coated with the immunizing antigen. The agglutinating capacity of sera from 
animals injected with HA-Ds or HA(Ox)s was completely inhibited by HA-Ds 
or HA(Ox)s, respectively, and was reduced one to two dilution steps by native 
HA (8). There was no consistent difference in this latter property between anti- 
TABLE III 
Incidence  of Agglutinating  Antibody  in  the  Sera  of Animals  Rendered  Tolerant  to  Human 
Albumin  and  Subsequently  Injected  with  Chemical  Derivatives of Human  Albumin 
Rabbits were injected with 20 mg human albumin (HA) at birth and were later injected 
with azo human albumin (HA-D) or oxazolonated human albumin HA(Ox) according to the 
following schedule. Injections with the chemical derivatives of HA were given on day 44, 
46, 48; 69, 71, 73; 94, 96, 98; 119, 121, 123; 144, 146, 148; 169, 171, 173; 194, 196, 198; 219, 
221,223 and 244, 246, 248. Bleedings were taken on days 54, 59; 78, 84; 103, 109; 128, 134; 
153, 159; 178, 184; 203, 209; 228, 234; 253, 259, and  the agglutinating titer was determined 
with tanned erythrocytes sensitized with the antigen employed for immunization. 
Human albumin 
derivative 
(HA-X*) used 
in immunizations 
HA-D 
HA(Ox) 
Totals... 
Average 
No. of 
hapten 
I~Aroups  per 
molecule 
8 
16 
35 
8 
38 
Fraction of responders$ (period in  days during which 
animals were immunized, and antigen (HA, HA-X*) with 
which tanned red cells were sensitized) 
73 days 
HA-X  ]  HA 
10/58  8/58 
2/12  0/12 
14/37  6/37 
1/40  1/40 
18/20  11/20 
45/167  26/167 
123 days 
HA-X  HA 
7/23  6/23 
2/10  0/10 
32/48  32/48 
1/10  1/10 
10/12  9/12 
52/103  48/103 
248days 
HA-X  HA 
6/lO  6/lO 
nd  nd 
4/8  4/8 
1/lo  1/lO 
10/12  9/12 
21/40  20/40 
nd, not done. 
* HA.X is HA-D8, HA-D16,  HA-D~, HA(Ox)s, or HA(Ox)38  depending on the antigen 
used for immunization. 
:~ Animals considered as antibody producers if antibody is found in any of the two bleed- 
ings taken after each course of injections. 
bodies obtained after two and nine courses.  After two courses of injections the 
agglutinating capacity  of  sera  from  animals  immunized with  HA(Ox)~  or 
HA-D3s  was not reduced by HA (7,  8).  This was also found with sera from 
animals given further courses of injections of HA(Ox)3s. However, in the sera of 
animals given four to nine courses of injections of I-IA-Da5 some degree of inhibi- 
tion was exercised by HA (1-5 dilution steps in 3/4 animals). 
The specificity of the antibody fraction reactive with HA, was examined with 
tanned cells coated with the native protein. The agglutinating capacity of anti- 
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pletely inhibited by HA-D8 and by HA, but more HA than HA-D8 was required 
for a  given degree of inhibition (8). This changed in the course of continued 
immunization, so that sera obtained after four to nine courses of injections, were 
inhibited to a similar extent by HA and HA-D8 (Fig. 3., rabbit 30-74 A). 
Sera obtained from animals given two courses of injections of HA-D35  re- 
acted only weakly with tanned erythrocytes coated with HA (mean log titer 
2.0  4-  0.3),  so  that  agglutination-inhibition  tests  could not  be  carried out. 
However, further immunizations with HA-D~5 produced antibodies which re- 
acted more strongly with tanned erythrocytes coated with HA (mean log titer 
I 
too; 
B0 i  I  "".--.--m--.--m.. 
.,;o  60  ~.  "i----i 
4  "~..o--  --e----o----e.-~-- ---~-  ,~-  --  o 
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tE.._.~q¢'..-....,---o  I  f  I  1  i  I  1 
0  I  2  3  4  5  6  7  8  9 
Number of courses  of injections 
FIG. 2. Response of rabbits which were injected with human albumin (HA) at birth and 
given nine courses of injections of chemically  modified derivatives of HA during adult life. 
Each point on the graph refers to the percentage of animals which made antibody after a 
particular course of injections (based on the agglutination of tanned cells coated with the 
immunizing  antigen). Animals  which  did not respond  at this stage are not included  even though 
they may have responded at a different  stage. ©, rabbits immunized  with HA-Ds; v1, rabbits 
immunized with HA(Ox)8; O, rabbits immunized with HA-D,g and  •  rabbits immunized 
with HA(Ox),s. 
3.5  4- 0.6). The agglutinating capacity of all these antibodies was more effec- 
tively inhibited by HA-D3~ than by HA. However, the relative quantities of HA 
and HA-D~5 required for comparable depression of titers varied between one and 
eight for sera from different individuals (curves in the lower half of Fig. 4). 
The HA-reactive antibody obtained after two courses of immunization with 
HA(Ox)~, differed from the HA-D antibodies, in being more reactive with HA 
than with the chemically modified antigen (7). In some animals continued im- 
munization with HA(Ox)~s  did not bring about a  substantial increase of titer 
and led to the continued production of this type of  antibody  (Fig. 3,  rabbit 
21-38 G). In other animals the properties of the antibody underwent a marked 
progressive  change,  in  that  agglutinating  capacity  was  equally  effectively 
inhibited by both antigens, or was more effectively inhibited by HA(Ox)~ than B. CINADER, ]. I% M. ST. ROSE, AND M. YOSHIMURA  1065 
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Fro. 3.  The antibody specificity of sera obtained from animals injected at birth with human  alb,,mln  (HA) 
and subsequently with chemically modified derivatives of HA. These curves represent three types of specifi- 
city changes found in sera from rabbits immunized with HA-D and  HA(Ox). Agglutination tests were caxried 
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by HA. In this type of animal, the antibody titer increased during continued 
immunization (Fig. 3, rabbit 21-42 E). 
We have thus detected a  progressive change in the properties of a fraction 
of the  total antibody which reacts with tanned cells  coated with HA. This 
change was not found in the sera of all the animals which responded to protein 
derivatives. Where it was observed, we also found triphasic elimination at the 
end of nine courses of immunization (Fig. 4). However, one animal did eliminate 
I-IAYlI triphasically, though the HA antibody after nine courses was of a type 
characteristic of the early antibody of other responders (Fig. 4, rabbit 30-83 H). 
In this animal the onset of immune elimination occurred 18 days after the injec- 
tion of HA.131I (t0.a =  450 hr). This value of t0.1 was similar to that of animals 
which were injected at birth but were not given cross-reacting antigens (Fig. 1). 
In contrast, the immune phase of elimination of all the other animals, which 
received antigen at birth  and cross-reacting antigen thereafter, started very 
much earlier than in animals which were injected at birth, received no cross- 
reacting antigens, and were tested at the same time as the animals injected with 
cross-reacting antigens (Fig. 1). 
Sensitivity of Antibody to Treatment with 2-Mercaptoethanol.--The agglutinat- 
ing capacity of sera  obtained from  13/31  animals which responded to  two 
courses of immunization with HA-D, could be  completely inhibited by pre- 
treatment with mercaptoethanol (8).  Antibodies obtained after three to nine 
courses of injections were mercaptoethanol insensitive in all but one serum. The 
mercaptoethanol-sensitive serum was obtained from a rabbit after seven Courses 
of injections of HA-D3s,  and this particular animal showed no detectable anti- 
body after the eighth and ninth course of injections. Another animal, which 
made antibody initially but not finally, lost its capacity to make antibody after 
the third course of injection of HA-Ds. The agglutinating capacity of the serum 
obtained after the second course was mercaptoethanol sensitive. 
The agglutinating capacity of sera obtained from 2/11  animals which re- 
sponded to two courses of immunization with HA(Ox)~, could be completely 
inhibited by pretreatment with mercaptoethanol. Antibodies obtained in all 
animals after the third and fourth courses of injections, were insensitive to 
mercaptoethanol. 
DISCUSSION 
Acquired ~mmunological tolerance may be considered as a regulatory mecha- 
nism, restricting the antibody response to determinants which are not identical 
with or similar to autologous macromolecules. Antibodies can only be elicited by 
determinants to which tolerance has not been induced unless tolerance is cir- 
cumvented. Autoantibody formation may sometimes be due to such circum- 
vention, and this can be studied by rendering animals tolerant to one antigen 
and immunizing them subsequently with a  cross-reacting antigen. The first 1068  CROSS-REACTING  ANTIGENS  AND  THE  TOLERANT  STATE 
studies of this type showed that an antibody could be obtained which possessed 
reactivity towards the tolerance-inducing  antigen (1). The connection between 
this reactivity and termination of tolerance was formulated by Weigle (13); it 
may perhaps be described better as "circumvention" since it may be attribut- 
able to antibodies which are directed against determinants which are not identi- 
cal  in  the  tolerance-induclng  and  in  the  immunizing  macromolecule  (8).  It 
appeared that there may also be other effects of the cross-reacting  antigen in 
that it might prolong the duration of tolerance.  This would not affect natural 
tolerance,  but might  be important  when  tolerance has been induced experi- 
mentally. An analysis of this effect is necessary if the regulatory consequences of 
natural tolerance (14, 15) are to be elucidated on the basis of model experiments. 
Most laboratory experiments differ in one important  respect from the condi- 
tions which prevail in naturally acquired tolerance: in the laboratory experi- 
ment antigen is provided discontinuously, in the natural system it is provided by 
synthesis and hence continuously. As a consequence of the discontinuous supply 
of tolerance-inducing  macromolecules,  tolerance is ultimately lost and  a  dy- 
namic situation must prevail prior to this.  In spite of this complication,  the dis- 
continuous  supply of  tolerance-inducing  macromolecules has  important  ad- 
vantages since this avoids removal of a fraction of antibody by combination 
with circulating  tolerance-inducing  macromolecules and hence permits detection 
of all antibodies.  However, it is necessary to differentiate between the extent to 
which cross-reacting  antigens prolong the tolerant state, and the extent to which 
they circumvent the tolerant state by inducing formation of antibodies with 
cross-reactivity towards the tolerance-inducing  macromolecule.  Circumvention 
may be attributed to antibodies which are evoked by determinants to which the 
animal is not tolerant. These antibodies are presumably the product of cells that 
cannot respond to the tolerance-inducing  macromolecules. 
The question arises whether, in addition, the cross-reacting  antigen preserves 
the inability of cells to respond to the tolerance-inducing  antigen.  To determine 
this,  we have  employed the  mode  of  elimination  of  the  tolerance-inducing 
macromolecule as an operational criterion of immune responsiveness.  By this 
means we have compared the responses  of animals  injected at birth and then 
immunized with cross-reacting  antigen with those of animals that were injected 
at birth but not further immunized.  By this criterion,  it has been clearly estab- 
lished that cross-reacting  antigens can prolong the duration of tolerance (Table 
II). This was also found when the incidence  in the immunized group (HA-Ds, 
HA-D~6, HA(Ox)s,  but not  HA(Ox)~)  of animals  which made agglutinating 
antibody, was compared with the incidence  of nonimmunized animals  which 
maintained tolerance as judged by elimination  tests. 
Tolerance can be prolonged indefinitely in all animals  if instead of the cross- 
reacting antigen, tolerance-inducing  antigen is given during later life (reference 
16, and Table II). A comparison of groups of animals  given,  during adult life, B.  CINADER,  J'.  E.  M.  ST.  ROSE,  AND  M,  YOSHIMURA  1069 
cross-reacting and tolerance-inducing antigen, respectively, reveals that toler- 
ance is better maintained by the antigen which was given at birth than by a 
cross-reacting  antigen  (Table  II).  To  identify this  difference with  antigen- 
induced circumvention of tolerance would obviously be erroneous, since it is, in 
fact, due to differences in the effectiveness with which tolerance is prolonged. 
We shall now turn to a consideration of factors which appeared to be related 
to the loss of tolerance in a proportion of the neonatally injected and immunized 
animals. The reactivity towards HA.131I of the antibody responders was distinct 
from that of nonimmunized neonatally injected animals. Animals which did 
respond to cross-reacting antigen responded more promptly to HA.18JI than did 
animals which had not received cross-reacting antigen, that is, the third phase of 
immune elimination appeared earlier. 
The properties  of protein-specific antibodies from neonatally injected and 
subsequently immunized animals underwent changes in the course of prolonged 
immunization. Different changes were observed in animals immunized with 
HA-Ds, HA-Ds~, and HA(Ox)~. Animals which were given azo derivatives pro- 
duced antibody which became progressively better adapted to HA (Fig. 3). The 
situation was  somewhat more  complex in  tolerant animals which were im- 
munized with HA(Ox)~. In the initial response to this antigen all the responders 
made a  heteroclitic antibody (17)  which was better adapted to HA than to 
HA(Ox)s8  (7).  This kind of antibody continued to be formed in some animals 
during the course of further injections, while in other animals it became equally 
or better adapted to HA(Ox)~ (Fig. 3). Therefore two distinct families of anti- 
body have to be taken into account. The presence of heteroclitic antibody may 
obscure the specificity changes which are clearly seen in the response to HA-D. 
Our data on specificity changes do not allow us to decide whether this change 
is due to antibodies which are adapted to the same site and to a progressively 
wider area surrounding the site (5,  18),  or whether there is synthesis of new 
types of antibodies against determinants which were originally excluded from 
immunogenicity, but can induce antibody formation in a  population of ceils 
which appears as the animal becomes older. We can obtain some insight into 
this problem from the changes in antibody quantity. 
In the course of immunization most neonatally injected animals reached a 
peak titer by the fourth course of immunization. After further immunization a 
constant titer was maintained or a decrease in titer occurred, sometimes to the 
point at which antibody could not be detected. This was previously observed 
(2,  19)  and has been described as a  "return of the tolerant state," (19).  In 
actual fact it may represent an instance of feedback inhibition (20-23).  In an 
animal which is not tolerant to a  cross-reacting antigen, a  large number of 
determinants are immunogenic and antibody directed against some of these 
may have induced feedback inhibition when other determinants may have not 
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an antigen, the number of determinants is much more restricted and feedback 
inhibition,  therefore,  might be more readily detected. The above  mentioned 
inhibition was observed in six animals immunized with HA(Ox)38, two animals 
immunized with HA-D35, and one animal immunized with HA-D8. In most of 
these animals (8/9)  the antibodies detected with cells coated with the modified 
antigen and with HA did not disappear at the same time. As a rule the antibody 
directed to HA disappeared  first (7/9 animals).  It seems likely that this asyn- 
chronous disappearance of antibodies is not due to the relative sensitivity of the 
method by which they are detected and is attributable to their production by 
different cell populations.  This phenomenon was  only observed  during  the 
period in which most animals would have lost tolerance if they had not been 
given the cross-reacting  antigen.  The loss of tolerance  of immunized animals 
may thus be attributable to cell populations which recovered from tolerance or 
which appeared during this period by differentiation from stem cells, and were 
sensitive  to  determinants which  are very similar  in  tolerance-inducing  and 
immunizing macromolecules. 
Among animals immunized with HA-D, feedback inhibition may perhaps be 
connected with the mercaptoethanol sensitivity of the antibody. Antibodies 
formed early by tolerant animals and also by normal animals were sensitive to 
treatment with 2-mercaptoethanol  (8); antibodies formed after repeated injec- 
tions were resistant to 2-mercaptoethanol.  The loss of the ability to produce 
agglutinating antibody was preceded by the continued presence or reappearance 
of mercaptoethanol-sensitive  antibody. Whether the antibody is implicated in 
the loss of the ability to continue producing antibody is not clear, but it has 
been shown that antibodies which are sensitive to 2-mercaptoethanol  can inhibit 
the immune response (21, 24). 
We have suggested that prolongation of tolerance did not occur when antigen- 
sensitive cells appeared and responded  to determinants which were similar in 
tolerance-inducing and immunizing antigen. We shall examine this now in terms 
of the rdation between circulating antibody and the interval between injection 
and immune elimination of HA.mI. Both the quantity and specificity of  the 
antibody elicited  by cross-reacting  antigen, appeared  to  affect the mode of 
elimination of HA.mI. All animals which showed high levels of agglutinating 
antibodies appeared to eliminate HA.13~I triphasically,  but so did some animals 
whose sera showed no prior reactivity with native antigen. In both these groups 
the onset of the immune phase was earlier than in animals which were injected at 
birth, but were not immunized subsequently (Fig.  1). Clearly,  the modified 
antigens had "primed" cells of the responding, neonatally  injected animals, even 
if this had not resulted in prior antibody formation. 
The specificity of the HA-antibody was not identical in all responding  ani- 
mals. If this reactivity could be inhibited by HA as effectively as by modified 
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(Fig. 4). Thus the presence of antibodies which were well adapted to HA ap- 
peared to indicate that an animal would go on to lose tolerance. The exceptional 
loss of tolerance in one animal  (Fig. 4, rabbit 30-83 H)  that made antibody 
which was  poorly adapted  to HA probably involved a  different mechanism 
since the inception of immune elimination occurred very late;  t0.1 =  450 hr. 
This value of t0a is comparable to that of animals which lost tolerance sponta- 
neously and had not been injected with cross-reacting antigen. 
In animals,  immunized with HA(Ox)3s, the production of heteroclitic anti- 
bodies ~as not related to loss of tolerance. Triphasic elimination was only ob- 
served if antibody evolved which was similar in specificity to that described for 
animals immunized with HA-D. 
We have thus seen that cross-reacting antigen can prolong the duration of 
tolerance. Some animals do not show this effect and form antibodies which may 
be produced by cells which arise after attrition of the neonatally induced toler- 
ance and which are sensitive to determinants of the tolerance-inducing antigen. 
SUMMARY 
Rabbits were rendered tolerant to human albumin (HA) and were then in- 
jected with azo and oxazolonated derivatives of human albumin. These injec- 
tions were continued to a time at which all animals would have lost tolerance if 
they had not been injected. Injection of cross-reacting antigens prolonged the 
duration of tolerance, as judged by the mode of elimination of lightly iodinated 
human albumin (HA.181I). Different derivatives of HA differed in their capacity 
to prolong tolerance. 
Those neonatally injected rabbits which were immunized with cross-reacting 
antigens and lost tolerance, responded much more promptly to HAYlI  than 
animals  which were not  immunized.  Animals immunized with  cross-reacting 
antigen which went on to eliminate HA.mI triphasically, usually had responded 
earlier by making antibodies. These antibodies contained a fraction which was 
reactive with HA, and which was usually equally well adapted to determinants 
on HA and on the cross-reacting antigen. 
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